/antiaging

antiaging

A Bold Perspective on Investing: Neal Bhadkamkar, General Partner, Bold Capital Partners Neal brings more than 30 years of investment and start-up experience as General Partner of BOLD. Previously, Neal was co-founder and General Partner of Monitor Ventures (an early …

Paul Krugman wrote an opinion piece where he rants against future radical life extension. Krugman fears that it will only be available to billionaires. Krugman scenario is that Peter Thiel would still be alive, wealthy and healthy in 2067 when …

Lifespan.io has a list of antiaging treatments and their stage of clinical approval. There are two treatments in phase 3 clinical trials and four in phase 2 clinical trials. The phase 2 clinical trials are two senescent cell treatments and …

Rejuvenate Bio Using Gene Therapy Has Reversed Aging Effects in Mice and Dogs

Rejuvenate Bio is offering a cardio-protective gene therapy that can stop the progression of MVD (Mitral Valve Disease). They are preparing to run a pilot study in dogs with MVD.

The top antiaging research at Sinclair’s lab is partial cellular reprogramming. He feels this is more powerful than senescent cell removal or calorie restriction. His lab in 2018 was able to regrow the optic nerve of a mouse.

Six brothers and sisters of one family reached over 100 years of age and show that genetic engineering would make it possible to live decades longer than most people live now.

What is aging? We can define aging as a process of accumulation of the damage which is just a side- effect of normal metabolism. While researchers still poorly understand how metabolic processes cause damage accumulation, and how accumulated damage causes …

Some people believe that successful antiaging would have a huge impact on social security and Medicare. They believe that if breakthrough medicine reduced the death probability each year three times, then this would bankrupt social security or Medicare. If someone …

In April, aging research expert Norman E. (Ned) Sharpless, MD will become the acting commissioner of the Food and Drug Administration. Dr. Sharpless is a 2003 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar. Ned served on …